Basel Medical (BMGL) Group announced that its subsidiary has been awarded a significant contract worth S$375M by Pancare Technology International to supply essential healthcare products in Asia-Pacific over the next five years until October 31, 2029. This milestone underscores the Company’s commitment to delivering high-quality medical solutions and strengthening its global presence in the healthcare sector. As part of the Company’s strategic vision, the Company will be accelerating the integration of AI-powered technologies into its healthcare supply chain operations. This initiative aims to enhance efficiency, optimize logistics, and to ensure the timely delivery of critical medical products to healthcare providers across Asia-Pacific and beyond.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMGL:
- Basel Medical Group Initiates $1 Billion Bitcoin Acquisition Strategy
- Basel Medical begins negotiations for $1B bitcoin acquisition
- Basel Medical Group Completes Acquisition of Bethesda Medical
- Basel Medical Group Announces Leadership Changes in April 2025
- Basel Medical Group Expands with Acquisition of Bethesda Medical